Skip to content
HowShorted

Replimune Group, Inc. short interest in 2022

In 2022, Replimune Group, Inc.'s disclosed short interest ran from 2.66% of shares outstanding on 14 Jan 2022 to 3.26% on 30 Dec 2022, a change of +0.60 percentage points. The year's high was 4.74% on 13 May 2022 and its low 2.66% on 14 Jan 2022, averaging 3.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.92 days on 29 Jul 2022. Full history: Replimune Group, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Replimune Group, Inc. in 2022

2022 in figures

Start of year
2.66% (14 Jan 2022)
End of year
3.26% (30 Dec 2022)
Change
+0.60 pp
High
4.74% (13 May 2022)
Low
2.66% (14 Jan 2022)
Average
3.64%
Highest days to cover
11.92 (29 Jul 2022)
SEC filings marked
8

Every report in 2022

Replimune Group, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20222.66%4.91
31 Jan 20222.88%5.29
15 Feb 20223.11%4.0410-Q filed, results (8-K)
28 Feb 20223.70%5.60
15 Mar 20223.89%6.02
31 Mar 20224.50%5.50
14 Apr 20223.87%4.04
29 Apr 20223.88%4.42
13 May 20224.74%5.28
31 May 20224.11%6.1710-K filed, results (8-K)
15 Jun 20223.90%5.73
30 Jun 20223.76%5.24
15 Jul 20223.66%9.25
29 Jul 20223.54%11.92
15 Aug 20223.17%6.9410-Q filed, results (8-K)
31 Aug 20223.19%6.91
15 Sep 20223.31%6.53
30 Sep 20223.80%5.22
14 Oct 20224.07%9.52
31 Oct 20224.03%5.34
15 Nov 20223.63%5.3910-Q filed, results (8-K)
30 Nov 20223.57%7.35
15 Dec 20223.20%1.73
30 Dec 20223.26%3.25

See also: Replimune Group, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.